Prolonged depression of thermoregulation after xylazine administration to cats
Authors:
- 1 December 1980
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 3 (4) , 203-207
Abstract
Xylazine administered subcutaneously (s.c.; 1–4 mg/kg) or intravenously (i.v.; 0.5‐2 mg/kg) to cats consistently caused dose‐related decreases in body temperature which were maximal 3–4 h after injection and lasted for at least 12 h. Otherwise the animals appeared to have recovered fully from the central nervous system effects of the drug within 1.5–3.5 h. Xylazine‐induced hypothermia developed more rapidly in cats placed in a 4°C environment and, in contrast, was replaced by a hyperthermic response in cats placed in a 32°C environment. These changes in body temperature were not opposed by compensatory thermoregulatory effector activity such as shivering or tachypnea. This pattern of responses at varied environmental temperatures is indicative of a general depression of the thermo‐regulation. Thus, animals given xylazine should not be exposed to extreme heat or cold for several hours to avoid development of hyper‐ or hypothermia.Keywords
This publication has 4 references indexed in Scilit:
- Naloxone resistant changes in body temperature of the cat induced by intracerebroventricular injection of pentazocineGeneral Pharmacology: The Vascular System, 1979
- Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agentsNeuroscience & Biobehavioral Reviews, 1979
- α2‐ADRENOCEPTORS MEDIATE CLONIDINE‐INDUCED SEDATION IN THE RATBritish Journal of Pharmacology, 1979
- Hypothermic effect of α-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugsNeuropharmacology, 1972